| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/02/2005 | US20050118244 penetration promoter; hormone replacement therapy; contraception |
| 06/02/2005 | US20050118243 Method and composition for delivering zinc to the nasal membrane |
| 06/02/2005 | US20050118242 Using testosterone; topical applying to skins |
| 06/02/2005 | US20050118241 emulsion comprises a mixture of lecithin(s), bile salts and cholesterol in water; advantage of the non-oily emulsion is the remarkably quick absorption of an active ingredient into the circulation |
| 06/02/2005 | US20050118236 composite scaffolds which are viable for tissue engineering of cartilage in vitro and transplanting the cartilage to a defect; bioactive, flexible, bioactive glass weaves and scaffolds with high porosity |
| 06/02/2005 | US20050118231 Water-soluble excipient biocompatible with an ophthalmic use: carbohydrates, gums, sodium salts, calcium salts, magnesium salts, maltodextrins, cellulose derivatives, chitosans, destructured/ partially hydrolyzed/crosslinked starches, polyvinyl alcohol, polyacrylic acid; disintegrate and release drug |
| 06/02/2005 | US20050118229 Implantable drug delivery device for sustained release of therapeutic agent |
| 06/02/2005 | US20050118226 Sustained-release implant releases ACAT inhibitor for a time effective to reduce ACAT activity; Alzheimer's disease, atherosclerosis; amyloid- beta reduction |
| 06/02/2005 | US20050118221 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound |
| 06/02/2005 | US20050118219 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone; rosacea and/or telangiectasia, skin aging |
| 06/02/2005 | US20050118217 Rapidly disintegrating films for delivery of pharmaceutical of cosmetic agents |
| 06/02/2005 | US20050118216 O/W emulsion containing an alkyltrimethylammonium bromide, uses thereof, method of making |
| 06/02/2005 | US20050118211 Water-in-oil emulsion composition and emulsion cosmetic comprising the same |
| 06/02/2005 | US20050118208 11-, 13-octadecadienoic acid isomers, 8-, 10-octadecadienoic acid isomers; foods, food supplements, feedstuffs, feed additives, pharmaceutical, cosmetic preparations |
| 06/02/2005 | US20050118206 A surfactant, a solvent, and a beneficial agent; exposure to a hydrophilic environment, surfactant and solvent form a viscous gel and beneficial agent dispersed or dissolved in the gel; |
| 06/02/2005 | US20050118205 Artificial sweetener, a sugar sweetener and a flavoring agent to mask a bitter antibiotic such as levofloxacin |
| 06/02/2005 | US20050118204 Methods for controlling membrane permeability of a membrane permeable substance and screening methods for a membrane permeable substance |
| 06/02/2005 | US20050118202 Keeping the equilibrium moisture content at 10% or above and/or adding ascorbic acid or a salt thereof to stabilize fused nitrogen heterocyclic ring compounds e.g. 5,6-dimethoxy-2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline,a potential drug for neurodegeneration |
| 06/02/2005 | US20050118201 Formalin inactivated preparations of mycobacteria, e.g., M. bovis, mixed with oil-containing nonphospholipid paucilamellar lipid vesicles e.g. Novasomes (reg); can be used on immunocomprised patients |
| 06/02/2005 | US20050118194 Oral vaccine, method for its preparation and use thereof |
| 06/02/2005 | US20050118167 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof |
| 06/02/2005 | US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors |
| 06/02/2005 | US20050118163 Antibody-containing solution pharmaceuticals |
| 06/02/2005 | US20050118114 Pulmonary insulin crystals |
| 06/02/2005 | US20050118113 Powder particles with smooth surface for use in inhalation therapy |
| 06/02/2005 | US20050118108 Active agent combined with liquid carrier comprised of liquid fluorocarbon, cosolvent, phospholipid and excipients; electrohydrodynamic aerosol spraying |
| 06/02/2005 | US20050118107 Formoterol combined with polyvinylpyrrolidone, polyethylene glycol, HFA 227 and HFA 134a; stable in pressurized meter dosage interior coated cans fitted with retention valve |
| 06/02/2005 | US20050118104 For enhanced echocardiographic imaging; an injectable aqueous gas dispersion and a coadministerable vasodilator capable of diffusing into the gas |
| 06/02/2005 | US20050118101 Delivery across skin or blood brain barrier; such as N-(fluorescein-5-yl)-thioureido-N'-Adoa-(polylysine)7-NH2 TFA salt |
| 06/02/2005 | US20050116247 Bonded products and methods of fabrication therefor |
| 06/02/2005 | DE10352277A1 Pulverinhalator Powder inhaler |
| 06/02/2005 | DE10351301A1 Pharmaceutical formulation, for oral administration, has a coating of film-forming polymers free of surfactants and anti-foaming agents |
| 06/02/2005 | DE102004053107A1 Matrix structure for induction of neofascia, especially for treatment of hernias, comprising flat matrix of biocompatible, bioresorbable synthetic polymer with surface suitable for immobilizing tissue cells |
| 06/02/2005 | CA2588012A1 Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents |
| 06/02/2005 | CA2548615A1 Non-tabletted, chewable, individually dosed administration forms |
| 06/02/2005 | CA2547881A1 Prevention of and countermeasures against viral infection |
| 06/02/2005 | CA2546794A1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 06/02/2005 | CA2546558A1 A method and process for controlling the temperature, pressure-and density profiles in dense fluid processes |
| 06/02/2005 | CA2546404A1 Method and composition for treatment or prophylaxis of amyloidosis disorders |
| 06/02/2005 | CA2546396A1 Method and composition for treatment of cutaneous lesions |
| 06/02/2005 | CA2546227A1 Methods of preparing a foam comprising a sclerosing agent |
| 06/02/2005 | CA2546200A1 Olanzapine containing transdermal drug delivery compositions |
| 06/02/2005 | CA2546108A1 Methods of preparing a foam comprising a sclerosing agent |
| 06/02/2005 | CA2546076A1 Therapeutic foam |
| 06/02/2005 | CA2545923A1 Excipients in drug delivery vehicles |
| 06/02/2005 | CA2545919A1 Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer |
| 06/02/2005 | CA2545915A1 Minimization of drug oxidation in drug irradiated excipients formulations |
| 06/02/2005 | CA2545913A1 An injectable depot gel composition, a method of preparation and use thereof |
| 06/02/2005 | CA2545856A1 Compositions comprising antibodies and methods of using the same for targeted nanoparticulate active agent delivery |
| 06/02/2005 | CA2545855A1 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 06/02/2005 | CA2545834A1 Controlled release of topiramate in liquid dosage forms |
| 06/02/2005 | CA2545800A1 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 06/02/2005 | CA2545726A1 Use of interferon tau for the treatment of obesity and for promotion of weight loss |
| 06/02/2005 | CA2545615A1 Methods and reagents for the treatment of inflammatory disorders |
| 06/02/2005 | CA2545608A1 Product of fibrous material providing a fresh feeling for skin by contact therewith |
| 06/02/2005 | CA2545513A1 Solid pharmaceutical preparation form |
| 06/02/2005 | CA2545399A1 Protein-polysaccharide microcapsules for delivering active agents to the gi tract |
| 06/02/2005 | CA2545219A1 Efficient introduction of an aerosol into a ventilator circuit |
| 06/02/2005 | CA2543072A1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | CA2540965A1 Process for preparing clopidogrel compositions |
| 06/02/2005 | CA2540159A1 Extended release venlafaxine formulation |
| 06/01/2005 | EP1535925A1 4,4-Diarylbutadiene functionalized methyltrialkylsilanes and cosmetic or photoprotective dermatological compositions containing them |
| 06/01/2005 | EP1535903A1 Modified MscL protein channel |
| 06/01/2005 | EP1535623A1 Renal cell carcinoma treatment |
| 06/01/2005 | EP1535617A1 Remedy or preventive for keratoconjunctival epithelial cell injury |
| 06/01/2005 | EP1535615A1 Composition for nasal absorption |
| 06/01/2005 | EP1535595A1 Process for producing aspheric seamless capsule and apparatus therefor |
| 06/01/2005 | EP1534682A1 Novel molecules derived from noraporphine |
| 06/01/2005 | EP1534512A1 Coated particles, methods of making and using |
| 06/01/2005 | EP1534508A1 Embossable and writable multilaminate backing construction |
| 06/01/2005 | EP1534370A1 Therapeutic aerosol device |
| 06/01/2005 | EP1534355A1 Silicone blends and composites for drug delivery |
| 06/01/2005 | EP1534351A1 Embolization |
| 06/01/2005 | EP1534339A1 Topical anhydrous and ethanol-free ascomycin compositions |
| 06/01/2005 | EP1534326A2 Improved bacterial outer membrane vesicles |
| 06/01/2005 | EP1534317A2 N-terminally truncated galectin-3 and antibodies for treating cancer |
| 06/01/2005 | EP1534313A2 Ophthalmologic irrigation solutions and method |
| 06/01/2005 | EP1534304A1 An analgesic agent for newborn or fetal subjects |
| 06/01/2005 | EP1534298A2 Novel anticholesterol compositions and method for using same |
| 06/01/2005 | EP1534296A1 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/01/2005 | EP1534288A1 Stable aqueous solutions of risperidone and methods for their preparation |
| 06/01/2005 | EP1534283A1 Formulation of liposomal derivatives of phenylalanine |
| 06/01/2005 | EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 06/01/2005 | EP1534259A2 Sulfonamides as potassium channel blockers |
| 06/01/2005 | EP1534253A1 Process for making orally consumable dosage forms |
| 06/01/2005 | EP1534252A2 Breath freshening and oral cleansing product using cardamom oil |
| 06/01/2005 | EP1534251A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534249A1 Chewable soft capsule |
| 06/01/2005 | EP1534248A1 Lasofoxifene tablet and its coating |
| 06/01/2005 | EP1534247A1 Methods for coating substrates for pharmaceutical uses with a mixture of two film-forming coating agents |
| 06/01/2005 | EP1534246A1 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| 06/01/2005 | EP1534245A1 Rapidly disintegrating tablet |
| 06/01/2005 | EP1534244A1 Methods and compositions for treating benign gynecological disorders, contraception, and hormone replacement |
| 06/01/2005 | EP1534243A1 Treating alzheimers using delipidated protein particles |
| 06/01/2005 | EP1534242A2 Buccal, polar or non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 06/01/2005 | EP1534241A1 Transdermal aerosol compositions |
| 06/01/2005 | EP1534240A1 Colloidal drug carrier system |
| 06/01/2005 | EP1534239A2 Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole |
| 06/01/2005 | EP1534238A1 Formulations and dosage forms for controlled delivery of topiramate |